Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol vs placebo on NT-proBNP in type 1 diabetic nephropathy
2009-011255-44Phase 2Completed
- Sponsor
- Steno Diabetes Center
- Start
- Jun 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetes mellitus type 1 (T1D), diabetic glomerulosclerosis and chronic kidney disease (CKD) comparing Paricalcitol (Zemplar) with Placebo (2 arms). Primary endpoint: Plasma NT-proBNP change. Started Jun 2009; status: completed.
02
Drugs
paricalcitol
03
Conditions
diabetes mellitus type 1 (T1D)diabetic glomerulosclerosischronic kidney disease (CKD)
Beyond the preview
Go deeper on 2009-011255-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011255-44.